Catawba Research (India) Private Limited

Catawba Research (India) Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U73100MH2019PTC331697 Incorporated 16 October 2019 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹9.86 Cr
▼ 2% YoY
Net profit · FY 2025
₹19.82 Lakh
Net margin 2%
EBITDA · FY 2025
₹24.25 Lakh
EBITDA margin 2.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹35 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
21
Provident fund records
Directors on board
3
As per MCA filings

About Catawba Research (India) Private Limited

Data last updated:

Catawba Research (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 October 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2019PTC331697. Its GSTIN is 27AAICC4253G1ZP (Maharashtra).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹35 Lakh. It is led by directors including Nicolaus Goldstein Joseph and Andrew Flint Silverman.

Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.86 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹19.82 Lakh (net margin 2%) and EBITDA of ₹24.25 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 125% over five years.

The company has about 21 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Catawba Research.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website catawbaresearch.com.

Company details

CIN U73100MH2019PTC331697
Registration Number 331697
Incorporation Date 16 October 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Catawba Research (India) Private Limited's registered office is in Mumbai, Maharashtra. Its website is catawbaresearch.com. Its e-mail address is in the company report.

  • Email
  • Social Media
  • Registered Address
    303 Antariksh Thakur House Marol Naka, Taluka Makwana Road Sir Mathuradas Vasanji Rd Marol Andheri East, Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Catawba Research (India) Private Limited, buy the company report.

Comprehensive company report
Catawba Research (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Catawba Research (India) operates one associated brand: Catawba Research. Each brand links to its own profile.

BrandDescriptionWebsite
Provider of clinical trial management services for pharmaceutical and biotechnology companiescatawbaresearch.com

Business activity

The main business activity of Catawba Research (India) is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Catawba Research (India) Private Limited, buy the company report.

Financials of Catawba Research (India) Private Limited

FY 2025 filings available

Catawba Research (India) Private Limited reported revenue of ₹9.86 Cr (down 2% YoY) for FY 2025.

Revenue · FY 2025
₹9.86 Cr ▼ 2%
Net profit · FY 2025
₹19.82 Lakh margin 2%
EBITDA · FY 2025
₹24.25 Lakh margin 2.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 18%
5 years · compounded
▲ 125%
EBITDA CAGR growth
1 year
▼ 83%
3 years · compounded
▼ 16%
5 years · compounded
▲ 25%

Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 125%. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹24.25 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹19.82 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.5%
Net Profit Margin2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Catawba Research (India) Private Limited, buy the company report.

Board of directors of Catawba Research (India) Private Limited

Catawba Research (India) has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nicolaus Goldstein JosephDirector05 Mar 20215 Years 8 MonthsCurrent
Andrew Flint SilvermanDirector19 Dec 20232 Years 10 MonthsCurrent
Subhashchandra PandeyAdditional Director28 Jul 20251 Years 3 MonthsCurrent

Auditor

Catawba Research (India) Private Limited is audited by A H K & COMPANY for the financial year 2020.

Auditor firmFinancial yearFirm registration number
A H K & COMPANYFY 2020326964E

Shareholding

The shareholding of Catawba Research (India) Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Catawba Research (India) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Catawba Research (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Catawba Research (India) Private Limited has a workforce of 21 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.

Employee count
21
Active EPFO establishments
1
Employee growth
23.53%

GST

Catawba Research (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAICC4253G1ZPMaharashtraActive06 Jan 2020

To see the full GST registrations and return filing status of Catawba Research (India) Private Limited, buy the company report.

Recent activity

Catawba Research (India) Private Limited has 9 board changes on record since 2021: 4 appointments and 5 cessations. The latest: Subhashchandra Pandey was appointed as Additional Director on 28 Jul 2025.

AGM
Catawba Research (India) Private Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records.
Appointed
Subhashchandra Pandey was appointed as Additional Director.
Filing
Catawba Research (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Zaidoon Ali Al Zubaidy ceased to be Director.
Appointed
Andrew Flint Silverman was appointed as Director.
Ceased
Lokesh Vishvanath Chaudhari ceased to be Additional Director.
Ceased
Praful Premji Bhanushali ceased to be Additional Director.
Appointed
Lokesh Vishvanath Chaudhari was appointed as Managing Director.
Ceased
Amit Keshav Naik ceased to be Director.
Ceased
Stephanie Stern Al Zubaidy ceased to be Director.
Appointed
Nicolaus Goldstein Joseph was appointed as Director.
Incorporation
16 Oct 2019
Catawba Research (India) Private Limited was registered on 16 Oct 2019 with Roc Mumbai & aged 7 years 24 days as per MCA records.

Frequently asked questions

Catawba Research (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 16 October 2019 (7+ years old) and is registered under CIN U73100MH2019PTC331697.

Catawba Research (India) has 3 current directors:

The latest financial statements of Catawba Research (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 August 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Catawba Research (India) is 27AAICC4253G1ZP, registered in Maharashtra.

The CIN (Corporate Identification Number) of Catawba Research (India) is U73100MH2019PTC331697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Catawba Research (India) was incorporated on 16 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.

Subhashchandra Pandey was appointed as Additional Director on 28 Jul 2025. Zaidoon Ali Al Zubaidy ceased to be Director on 01 May 2024. Andrew Flint Silverman was appointed as Director on 19 Dec 2023. Catawba Research (India) has 9 board changes on record in total.

Catawba Research (India) can be reached through the website catawbaresearch.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Catawba Research (India) is at 303 Antariksh Thakur House Marol Naka, Taluka Makwana Road Sir Mathuradas Vasanji Rd Marol Andheri East, Mumbai, Maharashtra, India – 400059.

Catawba Research (India) operates in the pharma industry, in the pharma contract r and d segment.